Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $19.1 million.

  • Veracyte's Consolidated Net Income rose 2633.35% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 42692.18%. This contributed to the annual value of $24.1 million for FY2024, which is 13244.18% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Consolidated Net Income is $19.1 million, which was up 2633.35% from -$980000.0 recorded in Q2 2025.
  • In the past 5 years, Veracyte's Consolidated Net Income registered a high of $19.1 million during Q3 2025, and its lowest value of -$41.9 million during Q1 2021.
  • Moreover, its 5-year median value for Consolidated Net Income was -$8.4 million (2023), whereas its average is -$7.2 million.
  • In the last 5 years, Veracyte's Consolidated Net Income plummeted by 63033.04% in 2023 and then soared by 47703.86% in 2025.
  • Quarter analysis of 5 years shows Veracyte's Consolidated Net Income stood at -$10.5 million in 2021, then skyrocketed by 63.16% to -$3.9 million in 2022, then tumbled by 630.33% to -$28.3 million in 2023, then soared by 118.16% to $5.1 million in 2024, then skyrocketed by 272.53% to $19.1 million in 2025.
  • Its last three reported values are $19.1 million in Q3 2025, -$980000.0 for Q2 2025, and $7.0 million during Q1 2025.